Cyclophosphamide and plasma exchange in multiple sclerosis-Reference-Cited by-同舟云学术

Cyclophosphamide and plasma exchange in multiple sclerosis

Published:1991-06 Issue:8756 Volume:337 Page:1540-1541
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Noseworthy JohnH,Vandervoort MargaretK,Penman Marie,Ebers George,Shumak Kenneth,Peter Seland T,Roberts Robin,Yetisir Elizabeth,Gent Michael,Wayne Taylor D

Publisher

Elsevier BV

Subject

General Medicine

Reference10 articles.

1. Chronic progressive multiple sclerosis: double-blind controlled study of plasmapheresis in patients taking immunosuppressive drugs;Khatri;Neurology,1985

2. Intensive immunosuppression in progressive multiple sclerosis: a randomised, three-arm study of high-dose intravenous cyclophosphamide, plasma exchange, and ACTH;Hauser;N Engl J Med,1983

3. IV cyclophosphamide ACTH plus maintenance cyclophosphamide boosters in progressive MS: final report of the Northeast Cooperative Treatment Group;Mackin;Neurology,1991

4. Interrater variability with the expanded disability status scale (EDSS) and functional systems (FS) in a multiple sclerosis clinical trial;Noseworthy;Neurology,1990

5. Interrater reliability in assessing functional systems and disability on the Kurtzke scale in multiple sclerosis;Amato;Arch Neurol,1989

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Assessing efficacy and safety of replacement fluids in therapeutic plasma exchange: A systematic scoping review of outcome measures used;Journal of Clinical Apheresis;2022-06-21

2. Multiple Sclerosis;International Encyclopedia of Public Health;2017

3. Multiple Sclerosis;International Encyclopedia of Public Health;2017

4. Neurotherapeutic Strategies for Multiple Sclerosis;Neurologic Clinics;2016-08

5. Observer bias in randomized clinical trials with time-to-event outcomes: systematic review of trials with both blinded and non-blinded outcome assessors;International Journal of Epidemiology;2014-01-20